deoxycytidine has been researched along with Leucocythaemia in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (36.76) | 18.7374 |
1990's | 19 (27.94) | 18.2507 |
2000's | 18 (26.47) | 29.6817 |
2010's | 6 (8.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Han, Z; Li, Y; Liu, G; Liu, J; van Zijl, PC; Zhang, J | 1 |
Campbell, DO; Czernin, J; Herschman, HR; Laing, RE; Phelps, ME; Radu, CG; Satyamurthy, N; Walter, MA; Witte, ON | 1 |
Adema, AD; Kathmann, I; Losekoot, N; Myhren, F; Peters, GJ; Sandvold, ML; Smid, K | 1 |
Bourgaux, C; Couvreur, P; Desmaële, D; Lepêtre-Mouelhi, S; Pili, B; Reddy, LH | 1 |
Cass, CE; Damaraju, VL; Karpinski, E; Mowles, D; Nowak, I; Robins, MJ; Smith, KM; Young, JD | 1 |
Adema, AD; Honeywell, RJ; Losekoot, N; Myhren, F; Peters, GJ; Sandvold, ML; Smid, K; Verheul, HM | 1 |
Fritzer-Szekeres, M; Golakoti, T; Graser, G; Jaeger, W; Krupitza, G; Madlener, S; Saiko, P; Schwarz, S; Somepalli, V; Szekeres, T | 1 |
Ames, MM; Avramis, VI; Krailo, MD; Liu-Mares, W; Reaman, GH; Reid, JM; Safgren, SL; Seibel, NL; Steinherz, PG | 1 |
Bacher, N; Hohla, F; Konwalinka, G; Mühlmann, O; Strasser-Wozak, E; Tiefenthaler, M; Wein, W | 1 |
Bresters, D; Broekhuizen, AJ; Faircloth, GT; Jimeno, J; Kaaijk, P; Kaspers, GJ | 1 |
BURCHENAL, JH; FOX, JJ; HEMPHILL, SC; HOLMBERG, EA; REPPERT, JA | 1 |
CALABRESI, P; CREASEY, WA; PRUSOFF, H; WELCH, AD | 1 |
DELAMORE, IW; PRUSOFF, WH | 1 |
EVANS, JS; MENGEL, GD | 1 |
Kolb, EA; Steinherz, PG | 1 |
Bergman, AM; Breistøl, K; Comijn, EM; Fodstad, O; Hendriks, HR; Kuiper, CM; Myhren, F; Noordhuis, P; Peters, GJ; Sandvold, ML; Smid, K; Voorn, DA | 1 |
Bergman, AM; Hendriks, HR; Kuiper, CM; Myhren, F; Peters, GJ; Sandvold, ML | 1 |
Dexheimer, TS; Fellows, IM; Gleason-Guzman, M; Hurley, LH; Schwaebe, M; Vankayalapati, H; Whitten, JP | 1 |
Bodo, J; Duraj, J; Rauko, P; Sedlak, J; Sulikova, M | 1 |
Couvreur, P; Desmaële, D; Dubernet, C; Marque, PE; Mouelhi, SL; Reddy, LH | 1 |
Adams, DJ; Giles, F; Jacobsen, TF; Myhren, F; Rizzieri, DA; Sandvold, ML | 1 |
Jekunen, A; Vilpo, JA | 1 |
Jones, SP; Sawyer, WH; Wiley, JS | 1 |
Andreeff, M; Blumenreich, MS; Chou, TC; Clarkson, BD; Vale, K; Young, CW | 1 |
Akman, SA; Bachur, NR; Ross, DD; Schrecker, AW | 1 |
Fox, RM; Tattersall, MH; Tripp, EH | 1 |
Arlin, Z; Fiori, L; Kreis, W; Leyland-Jones, BR; Yagoda, A | 1 |
Chapman, AJ; Chubb, S; Gandhi, V; Hertel, LW; Huang, P; Mineishi, S; Nowak, BJ; Plunkett, W; Yang, Y | 1 |
Csoka, K; Larsson, R; Liliemark, J; Nygren, P | 1 |
Eriksson, S; Kierdaszuk, B; Krawiec, K; Munch-Petersen, B; Shugar, D | 1 |
Aida, S; Ishida, N; Ishiwata, S; Itoh, K; Mizugaki, M; Yamaguchi, T | 1 |
Hata, Y; Prajda, N; Weber, G | 1 |
Baker, M; Bhalla, K; Grant, S | 1 |
Wiley, JS | 1 |
Huang, P; Iwasaki, H; Keating, MJ; Plunkett, W | 1 |
Heinemann, V; Issels, RD; Schulz, L; Wilmanns, W | 1 |
Dent, P; Grant, S; Kramer, LB; Povirk, LF; Saunders, AM; Vrana, JA; Zhang, XF | 1 |
Cvitkovic, E; Faivre, S; Raymond, E; Woynarowski, JM | 1 |
Inanami, O; Kuwabara, M; Matsuda, A; Nomura, Y; Takahashi, K | 1 |
Bergman, AM; Kroep, JR; Peters, GJ; Pinedo, HM; Ruiz van Haperen, VW; van Moorsel, CJ; Veerman, G; Voorn, DA | 1 |
Aresta, A; Liso, V; Palmisano, F; Specchia, G; Zambonin, CG | 1 |
Cass, CE; Clarke, ML; Gourdeau, H; Jolivet, J; Lafrenière, RG; Lee, N; Mackey, JR; Mowles, D; Ouellet, F; Richard, A; Selner, M; Young, JD | 1 |
Beauséjour, CM; Eliopoulos, N; Le, NL; Momparler, L; Momparler, RL | 1 |
Gandhi, V; Krett, N; Nabhan, C; Rosen, S | 1 |
Adams, DJ; Bass, AJ; Davis, P; DeCastro, CM; Foster, T; Gockerman, JP; Hurwitz, H; Jacobson, R; Laughlin, MJ; Moore, JO; Petros, WP; Rizzieri, DA; Rosner, GL | 1 |
Adams, DJ; Bass, AJ; Davis, P; DeCastro, CM; Foster, T; Gockerman, JP; Hammett, E; Moore, JO; Payne, N; Rizzieri, DA; Rosner, GL | 1 |
Chabner, BA; Coleman, CN; Drake, JC; Stoller, RG | 1 |
Chu, MY; Fischer, GA; Hoovis, ML | 1 |
Carson, DA; Kaye, J; Seegmiller, JE | 1 |
Hirt, A; Wagner, HP | 1 |
Arnér, ES; Eriksson, S; Spasokoukotskaja, T | 1 |
Nakamura, T; Ueda, T | 1 |
Du, M; Faucher, K; Grunewald, R; Kantarjian, H; Plunkett, W; Tarassoff, P | 1 |
Matsuda, A; Sasaki, T; Takenuki, K; Ueda, T | 1 |
Bhalla, K; Grant, S; McCrady, C | 1 |
Abbruzzese, J; Grunewald, R; Kantarjian, H; Keating, MJ; Plunkett, W; Tarassoff, P | 1 |
Gandhi, V; Plunkett, W | 1 |
Arlin, Z; Baker, M; Bhalla, K; Cole, J; Graham, G; Grant, S; MacLaughlin, W | 2 |
Akiyama, Y; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A | 1 |
Botti, RE; Imperia, PS; Lass, JH; Lazarus, HM; Mack, RJ | 1 |
Hiramoto-Yoshioka, A; Hirota, Y; Matsuda, A; Minowada, J; Otani, T; Tanaka, S; Ueda, T; Wataya, Y | 1 |
Akiyama, Y; Kiriyama, Y; Kitoh, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A | 1 |
Shirai, T; Umeda, M | 1 |
Fondu, P; Lebacq, AM; Mandelbaum, IM; Vertongen, F | 1 |
Bergstrom, D; Kahilainen, L; Kangas, L; Vilpo, JA | 1 |
Kinkade, JM | 1 |
Tarakanova, MP | 1 |
2 review(s) available for deoxycytidine and Leucocythaemia
Article | Year |
---|---|
Role of differentiation induction in action of purine antimetabolites.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Deoxycytidine; Gemcitabine; Humans; Leukemia; Oncogenes; Ribavirin | 1994 |
Gemcitabine in hematologic malignancies.
Topics: Antimetabolites, Antineoplastic; Clinical Trials as Topic; Deoxycytidine; DNA; Gemcitabine; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Tumor Cells, Cultured | 2001 |
8 trial(s) available for deoxycytidine and Leucocythaemia
Article | Year |
---|---|
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.
Topics: Adolescent; Biotransformation; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Chromatography, High Pressure Liquid; Deoxycytidine; Female; Gemcitabine; Half-Life; Humans; Infant; Leukemia; Male; Maximum Tolerated Dose; Metabolic Clearance Rate; Salvage Therapy | 2002 |
A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Dexamethasone; Drug Administration Schedule; Female; Gemcitabine; Humans; Leukemia; Male; Recurrence; Thiotepa; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine | 2003 |
Immunochemical detection of urinary 5-methyl-2'-deoxycytidine as a potential biologic marker for leukemia.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Biomarkers, Tumor; Chromatography, Affinity; Chromatography, High Pressure Liquid; Cross Reactions; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hybridomas; Immunochemistry; Leukemia; Mice; Mice, Inbred BALB C | 1995 |
Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
Topics: Adult; Aged; Blast Crisis; Cytarabine; Deoxycytidine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia | 1993 |
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mitoxantrone; Neural Tube Defects | 2002 |
Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Camptothecin; Deoxycytidine; Drug Administration Schedule; Esophagitis; Evaluation Studies as Topic; Female; Gemcitabine; Humans; Infusions, Intravenous; Irinotecan; Leukemia; Lymphoma; Male; Middle Aged; Nausea; Neutropenia; Recurrence; Stomatitis; Treatment Outcome; Vomiting | 2002 |
Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Evaluation; Gemcitabine; Humans; Leukemia; Middle Aged | 1992 |
An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents.
Topics: Adult; Aged; Aminoglycosides; Animals; Antineoplastic Agents; Antiviral Agents; Cells, Cultured; Cornea; Cytarabine; Deoxycytidine; Double-Blind Method; Epithelium; Female; Hodgkin Disease; Humans; Keratitis; Leukemia; Male; Middle Aged; Preservatives, Pharmaceutical; Rabbits; Thymidine; Toxicology | 1989 |
58 other study(ies) available for deoxycytidine and Leucocythaemia
Article | Year |
---|---|
Molecular Imaging of Deoxycytidine Kinase Activity Using Deoxycytidine-Enhanced CEST MRI.
Topics: Animals; Cell Line, Tumor; Deoxycytidine; Deoxycytidine Kinase; Female; Heterografts; Leukemia; Magnetic Resonance Imaging; Mice; Mice, Inbred NOD; Mice, SCID; Substrate Specificity | 2019 |
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography.
Topics: Animals; Antineoplastic Agents; Cytosine; Deoxycytidine; Gemcitabine; Humans; Leukemia; Mice; Positron-Emission Tomography | 2009 |
Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Cytidine Deaminase; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Nucleoside Deaminases; Polymerase Chain Reaction | 2010 |
Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
Topics: Animals; Antimetabolites, Antineoplastic; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Deoxycytidine; Gemcitabine; Leukemia; Liposomes; Mice; Particle Size; Polyethylene Glycols; Prodrugs; Scattering, Small Angle; Squalene; X-Ray Diffraction | 2010 |
Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Leukemia; Membrane Transport Proteins; Molecular Structure; Oocytes; Pyrimidine Nucleosides; Saccharomyces cerevisiae; Xenopus laevis | 2011 |
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.
Topics: Antineoplastic Agents; Cell Line; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Nucleoside Transport Proteins; Nucleotidases | 2012 |
Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cytarabine; Deoxycytidine; Gallic Acid; Gemcitabine; HL-60 Cells; Humans; Leukemia; Pancreatic Neoplasms; Stilbenes; Tumor Stem Cell Assay | 2011 |
Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.
Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Cells; Cell Division; Coculture Techniques; Cytotoxins; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Gemcitabine; Hematopoietic Stem Cells; HL-60 Cells; Humans; Immunosuppressive Agents; Leukemia; T-Lymphocytes | 2003 |
In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development.
Topics: Antineoplastic Agents; Blood Cells; Bone Marrow; Carnitine; Case-Control Studies; Cell Survival; Child; Deoxycytidine; Depsipeptides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Peptides, Cyclic; Podophyllotoxin | 2003 |
The effects of 5-fluorodeoxycytidine, 5-fluorodeoxyuridine, and related compounds on transplanted mouse leukemias.
Topics: Animals; Antineoplastic Agents; Deoxycytidine; Floxuridine; Leukemia; Leukemia, Experimental; Mice; Nucleosides; Nucleotides | 1959 |
Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine.
Topics: Adenocarcinoma; Bromodeoxycytidine; Carcinoma; Carcinoma, Squamous Cell; Deoxycytidine; Hodgkin Disease; Humans; Idoxuridine; Leukemia; Nucleosides | 1963 |
EFFECT OF DEOXYCYTIDINE ON THE RATE OF BIOSYNTHESIS OF PHOSPHORYLATED DERIVATIVES OF THYMIDINE.
Topics: Carbon Isotopes; Chromatography; Deoxycytidine; Formates; Idoxuridine; Leukemia; Leukemia, Experimental; Leukemia, Lymphoid; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Nucleosides; Nucleotides; Pharmacology; Phosphorylation; Research; Thymidine | 1964 |
THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cytarabine; Cytosine; Deoxycytidine; Leukemia; Leukemia, Experimental; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Research; Sarcoma 180 | 1964 |
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.
Topics: Animals; Antimetabolites, Antineoplastic; Carbon; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cytidine Deaminase; Deoxycytidine; DNA; DNA Damage; Fatty Acids; Gemcitabine; Humans; Inhibitory Concentration 50; Leukemia; Melanoma; Mice; Mice, Nude; Models, Chemical; Neoplasm Transplantation; Nucleoside Deaminases; Phosphorylation; Rats; Time Factors | 2004 |
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fatty Acids; Gemcitabine; Humans; Inhibitory Concentration 50; Leukemia; Mice; Neoplasms; Rats; Time Factors | 2004 |
Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line; Cell Line, Tumor; Deoxycytidine; DNA; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Epoxy Compounds; Gemcitabine; In Vitro Techniques; Inhibitory Concentration 50; Leukemia; Lymphoma; Mice; Mice, Nude; Models, Chemical; Models, Molecular; Pancreatic Neoplasms; Stereoisomerism; Time Factors; Xanthones | 2005 |
Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Busulfan; Cell Cycle; Cell Line, Tumor; Cycloheximide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gemcitabine; Humans; Leukemia; Paclitaxel; Resveratrol; Stilbenes | 2006 |
Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.
Topics: Animals; Antineoplastic Agents; Cytarabine; Deoxycytidine; Drug Evaluation, Preclinical; Gemcitabine; Leukemia; Mice; Mice, Inbred DBA; Nanomedicine; Nanostructures; Squalene; Treatment Outcome | 2008 |
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytarabine; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrazines; Idarubicin; Irinotecan; Leukemia; Lymphoma; Sulfonamides; Topotecan | 2008 |
5-Methyl-2'-deoxycytidine. Metabolism and effects on cell lethality studied with human leukemic cells in vitro.
Topics: Cell Division; Cell Line; Cell Survival; Deoxycytidine; Deoxyribonucleosides; Humans; Leukemia; Leukemia, Lymphoid | 1984 |
Cytosine arabinoside transport by human leukaemic cells.
Topics: Acute Disease; Adolescent; Adult; Aged; Biological Transport; Cell Membrane; Child; Child, Preschool; Cytarabine; Deoxycytidine; Humans; Infant; Kinetics; Leukemia; Leukocytes; Middle Aged; Phloretin; Thioinosine | 1983 |
Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Cytarabine; Deoxycytidine; Female; Humans; Interphase; Kinetics; Leukemia; Male; Middle Aged; Phosphorylation; Thymidine | 1984 |
Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Topics: Adenosine Deaminase; Cell Cycle; Cell Line; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Deoxyribonucleosides; Deoxyribonucleotides; DNA; Humans; Leukemia | 1981 |
Mechanism of deoxycytidine rescue of thymidine toxicity in human T-leukemic lymphocytes.
Topics: Cell Division; Cell Line; Deoxycytidine; Deoxyribonucleotides; DNA Replication; Humans; Leukemia; Lymphocytes; Ribonucleotide Reductases; Thymidine | 1980 |
Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease.
Topics: Adolescent; Adult; Aged; Animals; Deoxycytidine; Female; Humans; Leukemia; Leukemia, Experimental; Male; Mice; Mice, Inbred AKR; Mice, Inbred Strains; Middle Aged; Neoplasms; Thymidine Kinase | 1982 |
Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arabinonucleosides; Base Sequence; Cricetinae; Deoxycytidine; Deoxyguanosine; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Gemcitabine; Humans; Leukemia; Molecular Sequence Data; Nucleotides; Peptide Chain Elongation, Translational; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); RNA, Neoplasm; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms | 1995 |
Nucleoside triphosphate donors for nucleoside kinases: donor properties of UTP with human deoxycytidine kinase.
Topics: Adenosine Triphosphate; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Humans; Kinetics; Leukemia; Phosphorus Radioisotopes; Radioisotope Dilution Technique; Spleen; Substrate Specificity; Tritium; Uridine Triphosphate | 1995 |
Seeking the nucleoside transporter.
Topics: Animals; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Membrane; Cladribine; Cloning, Molecular; Cytarabine; Deoxycytidine; Erythrocytes; Gemcitabine; Glucose Transporter Type 1; Humans; Leukemia; Lymphoma; Membrane Proteins; Monosaccharide Transport Proteins; Nucleosides; Oocytes; Recombinant Proteins; Uridine; Vidarabine; Xenopus | 1997 |
Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells.
Topics: Antineoplastic Agents; Binding Sites; Cytarabine; Deoxycytidine; DNA Repair; DNA Replication; DNA, Neoplasm; Gemcitabine; Humans; Leukemia; Tumor Cells, Cultured; Vidarabine | 1997 |
Regulation of deoxycytidine kinase by deoxycytidine and deoxycytidine 5' triphosphate in whole leukemia and tumor cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; CHO Cells; Cricetinae; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; HL-60 Cells; Homeostasis; Humans; Leukemia; Ribonucleotide Reductases; Tumor Cells, Cultured | 1998 |
Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bryostatins; Cell Cycle Proteins; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytarabine; Deoxycytidine; Drug Interactions; Enzyme Activation; Gemcitabine; Humans; Lactones; Leukemia; Macrolides; Microtubule-Associated Proteins; Mitogens; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Suppressor Proteins; U937 Cells | 1999 |
Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Deoxycytidine; DNA; Gemcitabine; Humans; Leukemia; Organoplatinum Compounds; Oxaliplatin; Tumor Cells, Cultured | 1999 |
2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cladribine; Cycloheximide; Cysteine Proteinase Inhibitors; Deoxycytidine; DNA Fragmentation; DNA, Neoplasm; Enzyme Activation; fas Receptor; Flow Cytometry; Fluorometry; Humans; In Situ Nick-End Labeling; Leukemia; Oligopeptides; Phosphorylation; Tumor Cells, Cultured | 2000 |
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Leukemia; Lung Neoplasms; Mice; Ovarian Neoplasms; Rats; Ribonucleotide Reductases; Ribonucleotides; Tumor Cells, Cultured | 2000 |
Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia.
Topics: Acute Disease; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Deoxycytidine; Female; Humans; Leukemia; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudouridine; Sensitivity and Specificity | 1999 |
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
Topics: Amino Acid Sequence; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Male; Membrane Proteins; Molecular Sequence Data; Nucleoside Transport Proteins; Phosphorylation; Prostatic Neoplasms; Sequence Homology, Amino Acid; Sodium; Stereoisomerism; Tritium; Tumor Cells, Cultured; Uridine | 2001 |
Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Cells; Colony-Forming Units Assay; Cytarabine; Cytidine Deaminase; Decitabine; Deoxycytidine; DNA Modification Methylases; Drug Evaluation; Drug Resistance; Enzyme Inhibitors; Flow Cytometry; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Leukemia; Luminescent Proteins; Retroviridae; Transgenes | 2001 |
Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes.
Topics: Azacitidine; Blood Proteins; Cell Separation; Cell-Free System; Cytarabine; Cytidine Deaminase; Deoxycytidine; Granulocytes; Humans; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Molecular Weight; Phosphates; Phosphotransferases; Tissue Extracts; Uridine Kinase | 1975 |
Effects of 5-fluorodeoxyuridine on cell viability and uptake of deoxycytidine and (3H)cytosine arabinoside in L5178Y cells.
Topics: Animals; Cells, Cultured; Cytarabine; Deoxycytidine; DNA; Floxuridine; Kinetics; Leukemia; Mice; RNA | 1976 |
Metabolism and toxicity of 9-beta-D-arabinofuranosyladenine in human malignant T cells and B cells in tissue culture.
Topics: Adenosine Kinase; B-Lymphocytes; Cell Division; Cell Line; Deoxycytidine; Humans; Kinetics; Leukemia; T-Lymphocytes; Vidarabine | 1979 |
Nuclear incorporation of radioactive DNA precursors and progression of cells through S. Combined radioautographic and cytophotometric studies on normal and leukaemic bone marrow and thoracic duct lymph cells of man.
Topics: Aged; Bone Marrow; Bone Marrow Cells; Cell Nucleus; Child; Child, Preschool; Deoxycytidine; DNA; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lymphocytes; Male; Mitosis; Scleroderma, Systemic; Thymidine; Tritium | 1975 |
Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
Topics: Arabinonucleosides; Cladribine; Deoxycytidine; Deoxycytidine Kinase; Humans; Isoenzymes; Kinetics; Leukemia; Leukocytes; Mitochondria; Organ Specificity; Phosphorylation; Radioisotope Dilution Technique; Reference Values; Substrate Specificity; Thymidine; Thymidine Kinase; Tritium; Tumor Cells, Cultured; Zidovudine | 1992 |
[Clinical application of enzyme inhibitors--hematologic malignancies].
Topics: Cytarabine; Deoxycytidine; DNA Topoisomerases, Type I; Etoposide; Gemcitabine; Humans; Leukemia; Mercaptopurine; Methotrexate; Purines; Pyrimidines; Thioguanine; Topoisomerase I Inhibitors | 1991 |
Nucleosides and nucleotides. 94. Radical deoxygenation of tert-alcohols in 1-(2-C-alkylpentofuranosyl) pyrimidines: synthesis of (2'S)-2'-deoxy-2'-C-methylcytidine, an antileukemic nucleoside.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; Neoplasms; Structure-Activity Relationship | 1991 |
Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
Topics: Arabinofuranosylcytosine Triphosphate; Cell Division; Cytarabine; Cytidine Deaminase; DCMP Deaminase; Deamination; Deoxycytidine; Deoxycytosine Nucleotides; DNA, Neoplasm; Humans; Leukemia; Tetrahydrouridine; Tumor Cells, Cultured | 1991 |
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytidine Triphosphate; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia; Male; Middle Aged; Neoplastic Cells, Circulating | 1990 |
Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides.
Topics: Arabinonucleosides; Arabinonucleotides; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Leukemia; Phosphorylation; Tumor Cells, Cultured; Vidarabine | 1990 |
Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
Topics: Acute Disease; Azacitidine; Bone Marrow; Decitabine; Deoxycytidine; Deoxycytosine Nucleotides; DNA, Neoplasm; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1987 |
Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; B-Lymphocytes; Cell Line; Cytarabine; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine; Deoxycytosine Nucleotides; Humans; Hydroxyurea; Leukemia; T-Lymphocytes; Thymine Nucleotides; Vidarabine Phosphate | 1988 |
The mechanism of 2-chlorodeoxyadenosine-induced cell death.
Topics: 2-Chloroadenosine; Cell Survival; Cladribine; Cycloheximide; Deoxyadenosines; Deoxycytidine; DNA Damage; Humans; Leukemia; Lymphoma; Tumor Cells, Cultured | 1989 |
Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Deoxycytidine; Deoxycytosine Nucleotides; Drug Synergism; Humans; Hydroxyurea; Leukemia; Leukemia, Promyelocytic, Acute; Methotrexate; Thymine Nucleotides; Tumor Cells, Cultured | 1989 |
[Relationship between Ara-C sensitivity of leukemic-colony forming units (L-CFU) and [3H] deoxycytidine suicide test of L-CFU].
Topics: Adult; Aged; Cell Survival; Cytarabine; Deoxycytidine; Female; Humans; Leukemia; Male; Middle Aged; Neoplastic Stem Cells; Thymidine; Tritium; Tumor Stem Cell Assay | 1989 |
Deoxythymidine and deoxycytidine incorporation into DNA in B leukemic cells.
Topics: B-Lymphocytes; Deoxycytidine; Deoxycytidine Kinase; DNA; Humans; Leukemia; Phenotype; Thymidine | 1986 |
Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cytarabine; Deoxycytidine; DNA; Humans; Leukemia; Neoplastic Stem Cells; Phosphates; Stem Cells | 1987 |
In vitro and in vivo studies of a promising antileukemic thymidine analogue, 5-hydroxymethyl-2' deoxyuridine.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Cell Line; Deoxycytidine; Humans; Leukemia; Leukemia L1210; Thymidine | 1986 |
Effects of 5-bromo-2'-deoxyuridine (BUdR) on in vitro colony formation in cultures of mouse bone marrow cells.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bromodeoxyuridine; Cell Aggregation; Cells, Cultured; Centrifugation, Density Gradient; Chromatography, Gel; Chromatography, Ion Exchange; Culture Media; Deoxycytidine; DNA; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Male; Mice; Mice, Inbred C57BL; Proteinuria; Thymidine; Time Factors; Tritium | 1974 |
[Excretion of desoxycytidine in patients with leukemia following general gamma-irradiation].
Topics: Acute Disease; Deoxycytidine; Gamma Rays; Humans; Leukemia; Radiation Effects; Radiotherapy Dosage; Time Factors | 1971 |